6843-7 |
Apis mellifera Ab.IgE |
ACnc |
Ser |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Honey Bee IgE Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ALLERGY |
|
6843-7 |
|
|
|
|
Both |
|
|
|
0 |
Deprecated Honey Bee IgE Qn |
|
|
|
|
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Honey bee; Honeybee; i001; i1; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.69 |
1.0h(2) |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
68430-8 |
Leukocytes other |
NCnc |
Plr fld |
Pt |
Qn |
Manual count |
|
ACTIVE |
Leukocytes other [#/volume] in Pleural fluid by Manual count |
|
MIN |
DefinitionDescription |
|
|
10*9/L |
|
|
|
|
|
|
HEM/BC |
|
68430-8 |
|
Manual count |
|
|
Both |
|
|
|
0 |
WBC Other # Plr Manual |
|
|
|
N |
|
#; ABS; absolute; absolutes; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number concentration; Number Concentration (count/vol); Othr; Pleural; Pleural fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; thoracentesis fluid; WBC; WBC Other; WBCs; White blood cell; White blood cells |
2.7 |
2.38 |
|
|
|
|
|
|
|
10*3/uL |
|
|
|
0 |
68431-6 |
Leukocytes other |
NCnc |
Synv fld |
Pt |
Qn |
Manual count |
|
ACTIVE |
Leukocytes other [#/volume] in Synovial fluid by Manual count |
|
MIN |
DefinitionDescription |
|
|
10*9/L |
|
|
|
|
|
|
HEM/BC |
|
68431-6 |
|
Manual count |
|
|
Both |
|
|
|
0 |
WBC Other # Snv Manual |
|
|
|
N |
|
#; ABS; absolute; absolutes; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; Joint aspirate; Joint fld; Joint flu; Joint fluid; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number concentration; Number Concentration (count/vol); Othr; Point in time; QNT; Quan; Quant; Quantitative; Random; SF; SNV; Syn; Syn fl; Synov; Synovial fluid; WBC; WBC Other; WBCs; White blood cell; White blood cells |
2.7 |
2.38 |
|
|
|
|
|
|
|
10*3/uL |
|
|
|
0 |
68432-4 |
Leukocytes other/Leukocytes |
NFr |
Vitr fld |
Pt |
Qn |
Manual count |
|
ACTIVE |
Leukocytes other/Leukocytes in Vitreous fluid by Manual count |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
68432-4 |
|
Manual count |
|
|
Both |
|
|
|
0 |
WBC Other NFr Vitf Manual |
|
|
|
N |
|
HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Othr; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; VitF; Vitreous Fluid; Vitreous humor; Vitreous humour; WBC; WBC Other; WBCs; White blood cell; White blood cells |
2.79 |
2.38 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
68433-2 |
Leukocytes other |
NCnc |
Vitr fld |
Pt |
Qn |
Manual count |
|
ACTIVE |
Leukocytes other [#/volume] in Vitreous fluid by Manual count |
|
MIN |
DefinitionDescription |
|
|
10*9/L |
|
|
|
|
|
|
HEM/BC |
|
68433-2 |
|
Manual count |
|
|
Both |
|
|
|
0 |
WBC Other # Vitf Manual |
|
|
|
N |
|
#; ABS; absolute; absolutes; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number concentration; Number Concentration (count/vol); Othr; Point in time; QNT; Quan; Quant; Quantitative; Random; VitF; Vitreous Fluid; Vitreous humor; Vitreous humour; WBC; WBC Other; WBCs; White blood cell; White blood cells |
2.7 |
2.38 |
|
|
|
|
|
|
|
10*3/uL |
|
|
|
0 |
68434-0 |
Leukocytes |
NCnc |
Vitr fld |
Pt |
Qn |
Automated count |
|
ACTIVE |
Leukocytes [#/volume] in Vitreous fluid by Automated count |
|
MIN |
DefinitionDescription |
|
|
10*9/L |
|
|
|
|
|
|
HEM/BC |
|
68434-0 |
|
Automated count |
|
|
Both |
|
|
|
0 |
WBC # Vitf Auto |
|
|
|
N |
|
#; ABS; absolute; absolutes; Auto; Automated detection; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; Eye; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Number concentration; Number Concentration (count/vol); Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random; VitF; Vitreous Fluid; Vitreous humor; Vitreous humour; WBC; WBCs; White blood cell; White blood cells |
2.7 |
2.38 |
|
|
|
|
|
|
|
10*3/uL |
|
|
|
0 |
68435-7 |
Erythrocytes |
NCnc |
Vitr fld |
Pt |
Qn |
Automated count |
|
ACTIVE |
Erythrocytes [#/volume] in Vitreous fluid by Automated count |
|
MIN |
DefinitionDescription |
|
|
10*12/L |
|
|
|
|
|
|
HEM/BC |
|
68435-7 |
|
Automated count |
|
|
Both |
|
|
|
0 |
RBC # Vitf Auto |
|
|
|
N |
|
#; ABS; absolute; absolutes; Auto; Automated detection; Cnt; Count; Count/volume; CT; Discocytes; Elec; Elect; Electr; Erthrocyte; Erythrocyte; HEMATOLOGY/CELL COUNTS; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; VitF; Vitreous Fluid; Vitreous humor; Vitreous humour |
2.7 |
2.38 |
|
|
|
|
|
|
|
10*6/uL |
|
|
|
0 |
68436-5 |
Observation |
Aper |
Vitr fld |
Pt |
Nom |
|
|
ACTIVE |
Appearance of Vitreous fluid |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SPEC |
|
68436-5 |
|
|
|
|
Both |
|
|
|
0 |
Appearance Vitf |
|
|
|
N |
|
Appearance; Nominal; Point in time; Random; SPEC; Vitf; Vitreous fluid; Vitreous humor; Vitreous humour |
2.79 |
2.38 |
|
|
|
|
|
|
|
|
|
|
Release 2.79: COMPONENT: Triggered by coll w SCT: component that the description is property like as in Color, Appearance, Osmolality have changed to Component: Observation, and Property: Color, or Appearance, or Osmolality, so forth�; |
0 |
68437-3 |
Smudge cells |
NCnc |
Bld |
Pt |
Qn |
Manual count |
|
ACTIVE |
Smudge cells [#/volume] in Blood by Manual count |
|
MIN |
DefinitionDescription |
|
|
10*9/L |
|
|
|
|
|
|
HEM/BC |
|
68437-3 |
|
Manual count |
|
|
Both |
|
|
|
0 |
Smudge Cells # Bld Manual |
|
|
|
N |
|
#; ABS; absolute; absolutes; Basket cells; Blood; Cell; Cellularity; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; Manl; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.7 |
2.38 |
|
|
|
|
|
|
|
10*3/L |
|
|
|
0 |
68438-1 |
Calcidiol+ercalcidiol |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHEM |
|
68438-1 |
|
|
|
|
Both |
|
|
|
0 |
25(OH)D3+25(OH)D2 SerPl-sCnc |
|
|
|
N |
|
25 Hydroxyvitamin D 2; 25 Hydroxyvitamin D2; 25(OH)D2; 25(OH)D3; 25(OH)D3+25(OH)D2; 25-Hydroxy calciferol; 25-Hydroxy Vit D total; 25-Hydroxycalciferol; 25-hydroxycholecalciferol; 25-Hydroxyergocalciferol; 25-hydroxyvitamin D; 25-Hydroxyvitamin D 2; 25-hydroxyvitamin D 3; 25-Hydroxyvitamin D2; 25-hydroxyvitamin D3; 9,10-Secoergosta-5,7,10(19),22-tetraene-3 beta,25-diol; Calciderol; Calcidiol+Calciferol; Calcidiol+Ercalcidiol; Calcifediol; Chemistry; Ercalcidiol; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Vitamin D 25 hydroxy |
2.73 |
2.38 |
|
|
|
|
|
|
|
nmol/L |
|
|
Release 2.68: COMPONENT: Changed from vitamin-based name to chemical name to be consistent with other LOINC terms.; Previous Releases: Expanded Component name to clarify that this test is the combination of D2 and D3 of the primary 25-hydroxy form. |
0 |
68439-9 |
Gabapentin |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Gabapentin [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
Positive negative |
|
|
|
|
|
DRUG/TOX |
|
68439-9 |
|
|
|
|
Both |
|
|
|
0 |
Gabapentin Ur Ql |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Horizant; Neurontin; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.73 |
2.38 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
6844-5 |
Apis mellifera Ab.IgE |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Honey bee IgE Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
kIU/L |
|
|
|
|
|
|
ALLERGY |
|
6844-5 |
|
|
|
|
Both |
|
|
|
0 |
Honey bee IgE Qn |
|
|
|
Y |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Honey bee; Honeybee; i001; i1; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; UniversalLabOrders |
2.73 |
1.0h(2) |
|
|
|
|
|
|
|
k[IU]/L |
|
|
|
0 |
68440-7 |
Gamma hydroxybutyrate |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Gamma hydroxybutyrate [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
68440-7 |
|
|
|
|
Both |
|
|
|
0 |
G-OH-Butyr Ur-sCnc |
|
|
|
N |
|
4-hydroxybutyrate; 4-hydroxybutyric acid; Chemistry; Gamma hydroxy butyrate; Gamma-hydroxybutyrate; Gamma-OH; GBH; Georgia home boy; GHb; G-OH-Butyr; Goop; Hydroxybutyric acid; Level; Liquidx; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn |
2.7 |
2.38 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
68441-5 |
Gamma hydroxybutyrate |
SCnc |
Gast fld |
Pt |
Qn |
|
|
ACTIVE |
Gamma hydroxybutyrate [Moles/volume] in Gastric fluid |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
68441-5 |
|
|
|
|
Both |
|
|
|
0 |
G-OH-Butyr Gast-sCnc |
|
|
|
N |
|
4-hydroxybutyrate; 4-hydroxybutyric acid; Chemistry; Gamma hydroxy butyrate; Gamma-hydroxybutyrate; Gamma-OH; GAST; Gastric contents; Gastric fluid; GBH; Georgia home boy; GHb; G-OH-Butyr; Goop; Hydroxybutyric acid; Level; Liquidx; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration |
2.7 |
2.38 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
68442-3 |
Dialysis setting.primary |
Type |
^Patient |
Pt |
Nom |
|
|
TRIAL |
Primary dialysis setting |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.ESRD |
|
68442-3 |
|
|
|
|
|
|
|
|
0 |
|
|
ESRD.RQMT |
Primary dialysis setting |
N |
|
Dialy; ESRD; ESRD survey; Nominal; Point in time; Primary dialysis setting; Random; Survey; Typ |
2.4 |
2.38 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
68443-1 |
Dialysis.primary |
Type |
^Patient |
Pt |
Nom |
|
|
TRIAL |
Primary dialysis |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.ESRD |
|
68443-1 |
|
|
|
|
|
|
|
|
0 |
|
|
ESRD.RQMT_252 |
Primary type of dialysis |
N |
|
Dialy; ESRD; ESRD survey; Nominal; Point in time; Primary dialysis; Random; Survey; Typ |
2.4 |
2.38 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
68444-9 |
Date chronic dialysis began at current facility |
Date |
^Patient |
Pt |
Qn |
|
|
TRIAL |
Date chronic dialysis began at current facility |
|
MIN |
DefinitionDescription |
|
|
MMDDYY |
|
|
|
|
|
|
SURVEY.ESRD |
|
68444-9 |
|
|
|
|
|
|
|
|
0 |
|
|
ESRD.RQMT_256 |
Date patient started chronic dialysis at current facility |
N |
|
Date dialysis current facility; Dialy; ESRD; ESRD survey; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey |
2.5 |
2.38 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
68445-6 |
Date transplant |
Date |
^Patient |
Pt |
Qn |
|
|
TRIAL |
Date transplant |
|
MAJ |
DefinitionDescription |
|
|
MMDDYY |
|
|
|
|
|
|
SURVEY.ESRD |
|
68445-6 |
|
|
|
|
|
|
|
|
0 |
|
|
ESRD.RQMT_259 |
Transplant date |
N |
|
ESRD; ESRD survey; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey |
2.5 |
2.38 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
68446-4 |
Transplant facility name |
ID |
Facility |
Pt |
Nom |
|
|
TRIAL |
Transplant facility name |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.ESRD |
|
68446-4 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
N |
|
Admin; ESRD; ESRD survey; Ident; Identifier; Nominal; Point in time; Random; Survey |
2.38 |
2.38 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
68447-2 |
Date transplant admission |
TmStp |
^Patient |
Pt |
Qn |
|
|
TRIAL |
Date transplant admission |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.ESRD |
|
68447-2 |
|
|
|
|
|
|
|
|
0 |
|
|
ESRD.RQMT_263 |
Date patient was admitted as an inpatient to a hospital in preparation for, or anticipation of, a kidney transplant prior to the date of the actual tranplantation |
N |
|
Date and time; ESRD; ESRD survey; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; Time stamp; Timestamp |
2.44 |
2.38 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
68448-0 |
Dialysis sessions per W |
NRat |
^Patient |
Pt |
Qn |
|
|
TRIAL |
Dialysis sessions per week |
|
MIN |
DefinitionDescription |
|
|
#/week |
|
|
|
|
|
|
SURVEY.ESRD |
|
68448-0 |
|
|
|
|
|
|
|
|
0 |
|
|
ESRD.RQMT_253 |
Sessions per Week |
N |
|
Count/time; Dialy; ESRD; ESRD survey; nRate; Number rate; Number Rate = Count/Time; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey |
2.48 |
2.38 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
68449-8 |
Arteriovenous fistula maturity |
Find |
^Patient |
Pt |
Ord |
|
|
TRIAL |
Arteriovenous fistula maturity |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.ESRD |
|
68449-8 |
|
|
|
|
|
|
|
|
0 |
|
|
ESRD.RQMT_228 |
Is maturing AVF present? |
N |
|
ESRD; ESRD survey; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey |
2.44 |
2.38 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
6845-2 |
Latex glove extract ammoniated Ab.IgE |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Latex glove extract ammoniated IgE Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
kIU/L |
|
|
|
|
|
|
ALLERGY |
|
6845-2 |
|
|
|
|
Both |
|
|
|
0 |
Ltx Glv Ext Ammon IgE Qn |
|
|
|
Y |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Brazilian rubber tree; Hevea braziliensis; Immune globulin E; Immunoglobulin E; k082; k82; Ltx; Ltx Glv Ext; Ltx Glv Ext Ammon; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.73 |
1.0h(2) |
|
|
|
|
|
|
|
k[IU]/L |
|
|
|
0 |
68450-6 |
Graft maturity |
Find |
^Patient |
Pt |
Ord |
|
|
TRIAL |
Graft maturity |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.ESRD |
|
68450-6 |
|
|
|
|
|
|
|
|
0 |
|
|
ESRD.RQMT_229 |
Is maturing graft present? |
N |
|
ESRD; ESRD survey; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey |
2.44 |
2.38 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
68451-4 |
Self-dialysis training program - end stage renal disease form 2728 |
- |
^Patient |
Pt |
- |
|
|
TRIAL |
Self-dialysis training program - end stage renal disease form 2728 |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.SURVEY.ESRD |
|
68451-4 |
|
|
|
|
|
|
|
|
0 |
|
|
|
|
N |
|
Dialy; Dis; Diseases; Dz; End Stage Renal Disease (ESDR) pnl; End-stage renal disease; ESRD; ESRD survey; Kidney; Pan; Panel; Panl; Pnl; Point in time; Random; Self-dialysis training ESRD 2728; Survey |
2.38 |
2.38 |
|
Panel |
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |